Lipid Injectable Emulsion Survey with Gap Analysis

Michael Christensen, Phil Ayers, Joseph I. Boullata, Peggi Guenter, Kathleen M. Gura, Beverly Holcombe, David S. Seres, Gordon S. Sacks

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Lipid injectable emulsion (ILE) is an integral part of parenteral nutrition (PN), providing energy and essential fatty acids. With recent consensus recommendations for PN, clinical guidelines for ordering and preparation of PN, the U.S. Food and Drug Administration approval of new ILE products, and revised ILE labeling to include a 1.2-micron filter, a gap in current practice knowledge was apparent. Materials and Methods: The American Society for Parenteral and Enteral Nutrition PN Safety Committee surveyed clinicians on how ILE products are prescribed, prepared, and administered to patients from neonates to adults. Results: The results of this survey conducted in late 2016 found a wide variation in practice, particularly across patient age groups. Conclusion: These findings demonstrate the need for ongoing dissemination and education on standardized safe practices for ILE use.

Original languageEnglish (US)
Pages (from-to)694-702
Number of pages9
JournalNutrition in Clinical Practice
Volume32
Issue number5
DOIs
StatePublished - Oct 1 2017

Fingerprint

Emulsions
Parenteral Nutrition
Lipids
Injections
Drug Approval
Nutrition Policy
Essential Fatty Acids
United States Food and Drug Administration
Age Groups
Surveys and Questionnaires
Newborn Infant
Safety
Education

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Christensen, M., Ayers, P., Boullata, J. I., Guenter, P., Gura, K. M., Holcombe, B., ... Sacks, G. S. (2017). Lipid Injectable Emulsion Survey with Gap Analysis. Nutrition in Clinical Practice, 32(5), 694-702. https://doi.org/10.1177/0884533617719671

Lipid Injectable Emulsion Survey with Gap Analysis. / Christensen, Michael; Ayers, Phil; Boullata, Joseph I.; Guenter, Peggi; Gura, Kathleen M.; Holcombe, Beverly; Seres, David S.; Sacks, Gordon S.

In: Nutrition in Clinical Practice, Vol. 32, No. 5, 01.10.2017, p. 694-702.

Research output: Contribution to journalArticle

Christensen, M, Ayers, P, Boullata, JI, Guenter, P, Gura, KM, Holcombe, B, Seres, DS & Sacks, GS 2017, 'Lipid Injectable Emulsion Survey with Gap Analysis', Nutrition in Clinical Practice, vol. 32, no. 5, pp. 694-702. https://doi.org/10.1177/0884533617719671
Christensen M, Ayers P, Boullata JI, Guenter P, Gura KM, Holcombe B et al. Lipid Injectable Emulsion Survey with Gap Analysis. Nutrition in Clinical Practice. 2017 Oct 1;32(5):694-702. https://doi.org/10.1177/0884533617719671
Christensen, Michael ; Ayers, Phil ; Boullata, Joseph I. ; Guenter, Peggi ; Gura, Kathleen M. ; Holcombe, Beverly ; Seres, David S. ; Sacks, Gordon S. / Lipid Injectable Emulsion Survey with Gap Analysis. In: Nutrition in Clinical Practice. 2017 ; Vol. 32, No. 5. pp. 694-702.
@article{1e8234c9072740888f95e884782b939c,
title = "Lipid Injectable Emulsion Survey with Gap Analysis",
abstract = "Background: Lipid injectable emulsion (ILE) is an integral part of parenteral nutrition (PN), providing energy and essential fatty acids. With recent consensus recommendations for PN, clinical guidelines for ordering and preparation of PN, the U.S. Food and Drug Administration approval of new ILE products, and revised ILE labeling to include a 1.2-micron filter, a gap in current practice knowledge was apparent. Materials and Methods: The American Society for Parenteral and Enteral Nutrition PN Safety Committee surveyed clinicians on how ILE products are prescribed, prepared, and administered to patients from neonates to adults. Results: The results of this survey conducted in late 2016 found a wide variation in practice, particularly across patient age groups. Conclusion: These findings demonstrate the need for ongoing dissemination and education on standardized safe practices for ILE use.",
author = "Michael Christensen and Phil Ayers and Boullata, {Joseph I.} and Peggi Guenter and Gura, {Kathleen M.} and Beverly Holcombe and Seres, {David S.} and Sacks, {Gordon S.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1177/0884533617719671",
language = "English (US)",
volume = "32",
pages = "694--702",
journal = "Nutrition in Clinical Practice",
issn = "0884-5336",
publisher = "SAGE Publications Ltd",
number = "5",

}

TY - JOUR

T1 - Lipid Injectable Emulsion Survey with Gap Analysis

AU - Christensen, Michael

AU - Ayers, Phil

AU - Boullata, Joseph I.

AU - Guenter, Peggi

AU - Gura, Kathleen M.

AU - Holcombe, Beverly

AU - Seres, David S.

AU - Sacks, Gordon S.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Background: Lipid injectable emulsion (ILE) is an integral part of parenteral nutrition (PN), providing energy and essential fatty acids. With recent consensus recommendations for PN, clinical guidelines for ordering and preparation of PN, the U.S. Food and Drug Administration approval of new ILE products, and revised ILE labeling to include a 1.2-micron filter, a gap in current practice knowledge was apparent. Materials and Methods: The American Society for Parenteral and Enteral Nutrition PN Safety Committee surveyed clinicians on how ILE products are prescribed, prepared, and administered to patients from neonates to adults. Results: The results of this survey conducted in late 2016 found a wide variation in practice, particularly across patient age groups. Conclusion: These findings demonstrate the need for ongoing dissemination and education on standardized safe practices for ILE use.

AB - Background: Lipid injectable emulsion (ILE) is an integral part of parenteral nutrition (PN), providing energy and essential fatty acids. With recent consensus recommendations for PN, clinical guidelines for ordering and preparation of PN, the U.S. Food and Drug Administration approval of new ILE products, and revised ILE labeling to include a 1.2-micron filter, a gap in current practice knowledge was apparent. Materials and Methods: The American Society for Parenteral and Enteral Nutrition PN Safety Committee surveyed clinicians on how ILE products are prescribed, prepared, and administered to patients from neonates to adults. Results: The results of this survey conducted in late 2016 found a wide variation in practice, particularly across patient age groups. Conclusion: These findings demonstrate the need for ongoing dissemination and education on standardized safe practices for ILE use.

UR - http://www.scopus.com/inward/record.url?scp=85029759857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029759857&partnerID=8YFLogxK

U2 - 10.1177/0884533617719671

DO - 10.1177/0884533617719671

M3 - Article

VL - 32

SP - 694

EP - 702

JO - Nutrition in Clinical Practice

JF - Nutrition in Clinical Practice

SN - 0884-5336

IS - 5

ER -